CN1068209C - Feijiwan pill (for lung disease) and preparation method - Google Patents
Feijiwan pill (for lung disease) and preparation method Download PDFInfo
- Publication number
- CN1068209C CN1068209C CN96117648A CN96117648A CN1068209C CN 1068209 C CN1068209 C CN 1068209C CN 96117648 A CN96117648 A CN 96117648A CN 96117648 A CN96117648 A CN 96117648A CN 1068209 C CN1068209 C CN 1068209C
- Authority
- CN
- China
- Prior art keywords
- radix
- fried
- bletillae
- bulbus fritillariae
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine Feijiwan for treating tuberculosis and a manufacture method thereof. Traditional Chinese medicinal materials of radix asparagi, ophiopogon, laminaria, stemona root and bletilla striata which are moderately parched at a medium baking temperature, traditional Chinese medicinal materials of lily bulb, tuckahoe, coix, coastal glehnia root, tip shellfish and Zhejiang fritillaria which are dehydrated at a low baking temperature or by drying in the sun, and jingxia which is prepared from pinellia tuber in a conventional method are compounded by weight percentage and are crushed into powder; the powder, refined proportioning bee honey and distilled donkey-hide gelatin are uniformly mixed to prepare pills. The present invention has a certain curative effects on pulmonary tuberculosis pleurisy, hemoptysis, trachitis, child chicken breast, lung vacuity, debility, etc. The present invention integrates prevention, treatment and health care.
Description
The present invention relates to phthisical Chinese patent medicine of a kind of treatment and manufacture method thereof, is the pill that the raw materials of traditional Chinese medicinal materials compatibility is made.This Chinese patent medicine also has a certain curative effect to tuberculous pleuritis, tracheitis, cough haematemesis, children's's pigeon chest, the deficiency of the lung are weak etc.
At present, have with treatment by Chinese herbs is phthisical " spirit of bringing back to life ", become the cream external treatment, effect is not as treatment by oral administration of medicines, and " ointment for eliminating tuberculosis " consumption is big, and one day consumption is specially controlled each paratuberculous " Yuheshukangping-medicine for treatment of tuberculosis " more than 50 grams, the cost height, and expenses for medicine was up to 300-500 unit in every month.When generally using treatment by Chinese herbs at present, think that pulmonary tuberculosis is that the deficiency of YIN should be mended more, use Radix Ginseng, the Radix Astragali, Cordyceps, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Fructus Schisandrae Chinensis isothermal medicine more, dry lung, real that it is anti-.And the normal health medicine that lacks prevention, the lung tissue that keeps healthy, takes into account kidney,liver,spleen, stomach, intestinal, the heart in the medicine, curative effect is not very good.
The objective of the invention is to: invent a kind of with low cost, convenient phthisical Chinese patent medicine of treatment and manufacture method thereof that is suitable for of treatment.
The present invention realizes its purpose like this: this Chinese patent medicine system makes with the following weight percentages Chinese crude drug:
Radix Asparagi 1-6, sharp Bulbus Fritillariae Uninbracteatae 2-10, Radix Ophiopogonis 2-10, Colla Corii Asini 1-6,
Bulbus Fritillariae Thunbergii 1-8, Thallus Laminariae (Thallus Eckloniae) 5-10, capital Rhizoma Pinelliae 1-6, Radix Glehniae 1-5,
Poria 5-15, Semen Coicis 5-15, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-50, Radix Stemonae 5-15,
Bulbus Lilii 5-15, total amount is 100%.
The manufacture method of this Chinese patent medicine is: at first with the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Ophiopogonis, Radix Asparagi, the Radix Stemonae, Thallus Laminariae (Thallus Eckloniae) 80 ℃ to 120 ℃ parches of moderate heat, the Pseudobulbus Bletillae (Rhizoma Bletillae) was fried 1 to 2 hour, Radix Asparagi, fried Radix Ophiopogonis 0.5 to 1 hour, the Radix Stemonae was fried 20 minutes to 1 hour, Thallus Laminariae (Thallus Eckloniae) was fried 20 minutes to 40 minutes, then with Semen Coicis, Bulbus Lilii, Poria, Bulbus Fritillariae Thunbergii, Radix Glehniae, the point Bulbus Fritillariae Uninbracteatae descends or dries for 50 ℃ to 70 ℃ to dewater at low baking temperature, then with the treated medical material and the capital Rhizoma Pinelliae made by the Rhizoma Pinelliae, measure by weight percentage, be ground into powder, with the Mel refinery of dosage, evaporate Colla Corii Asini at last, make pill with the Chinese drugs powder mix homogeneously.
Further specify below in conjunction with embodiment, but be not limited only to this.
Example one
1, the raw medicinal material of Chinese patent medicine and percentage by weight thereof are:
Radix Asparagi 1, sharp Bulbus Fritillariae Uninbracteatae 2, Radix Ophiopogonis 2, Colla Corii Asini 1, Bulbus Fritillariae Thunbergii 2, Thallus Laminariae (Thallus Eckloniae) 5, the capital Rhizoma Pinelliae 1, Radix Glehniae 1, Poria 5, Semen Coicis 5, the Radix Stemonae 5, the Pseudobulbus Bletillae (Rhizoma Bletillae) 60, Bulbus Lilii 10, total amount is 100%.
2, make the method for this Chinese patent medicine
At first with the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Ophiopogonis, Radix Asparagi, the Radix Stemonae, the Thallus Laminariae (Thallus Eckloniae) moderate heat parch appropriateness with 80 ℃ to 120 ℃, the Pseudobulbus Bletillae (Rhizoma Bletillae) was fried 1 to 2 hour, and Radix Ophiopogonis, Radix Asparagi are fried half an hour to 1 hour, and the Radix Stemonae was fried 20 minutes to 1 hour, and Thallus Laminariae (Thallus Eckloniae) was fried 20 minutes to 40 minutes.Again with Semen Coicis, Bulbus Lilii, Poria, Bulbus Fritillariae Thunbergii, sharp Bulbus Fritillariae Uninbracteatae, Radix Glehniae with 50 ℃ to 70 ℃ low baking temperature or dry and dewater.Then with the treated medical material and the capital Rhizoma Pinelliae made according to a conventional method by the Rhizoma Pinelliae, with its percentage by weight metering, be ground into powder, the Mel of last refinery dosage, evaporate Colla Corii Asini, and with the medicinal powder mixing and stirring, make pill and get final product, the method of making pill is identical with conventional Chinese patent medicine pill method for making, and the dosage of Mel is 100% ± 5% of a raw materials of traditional Chinese medicinal materials gross weight.
3, medicine is supervised detection by Kaijiang County, Sichuan Province medicine inspecting institute.
Note, avoid when 4, treatment is used and the keeping requirement.
Instructions about how to take medicine: every day 2-4 time, day dose 25-35 gram is measured the 7-9 gram at every turn.Service once in 8 of breakfast, lunch and dinner ante cibum every day and evenings, take with the Flos Plumeriae Acutifoliae boiled water before the morning of every day, the supper, all the other times take with boiled water.Also can directly the pill fragmentation be swallowed.Avoid clothes during flu, or the clothes that reduce by half, take with boiled water.
Taboo: forbid sexual life in the treatment phase; Dry property foods such as fasting wine, cock, Cyprinus carpio, Fructus Piperis, hot pepper, Rhizoma Zingiberis Recens; Diet goose, sow, beef or mutton, white sugar and brown sugar; Edible crystal sugar and honey sugar; Take a good rest, avoid too tired.
Keeping: pill is deposited in the vial, places dry shady and cool place.
5, clinical trial and effect
Reach hospital and township hospital's therapeutic test in 2 cities, 5 counties, valley district in Sichuan Province, to 80 routine pulmonary tuberculosis patients, cure rate is more than 90%, effective percentage 100%.Generally looking state of an illness treatment can cure in 2-10 month.Through investigation, this medicine is taken for a long time and is not found any toxic and side effects liver,kidney,spleen, stomach, intestinal, the heart etc. are all had certain benefit, has the effect of strong lung tissue, has prevention, health care, treatment function.
Example two
1, the raw medicinal material of Chinese patent medicine and percentage by weight thereof are:
Radix Asparagi 3, sharp Bulbus Fritillariae Uninbracteatae 4, Radix Ophiopogonis 5, Colla Corii Asini 3, Bulbus Fritillariae Thunbergii 4, Thallus Laminariae (Thallus Eckloniae) 8, the capital Rhizoma Pinelliae 3, Radix Glehniae 3, Poria 15, Semen Coicis 12, the Pseudobulbus Bletillae (Rhizoma Bletillae) 20, the Radix Stemonae 15, Bulbus Lilii 5, total amount is 100%.
2, the Chinese patent medicine manufacture method, supervise that detection, treatment are noted, taboo and keeping require all with embodiment one.
3, clinical trial and effect.
Test hospital is with example one.To 100 routine tuberculosis treatments, cure rate 89%, effective percentage 99%, invalid 1%.All the other effects are with example one.
Example three
1, the raw medicinal material of Chinese patent medicine and percentage by weight are:
Radix Asparagi 3, sharp Bulbus Fritillariae Uninbracteatae 10, Radix Ophiopogonis 10, Colla Corii Asini 6, Bulbus Fritillariae Thunbergii 1, Thallus Laminariae (Thallus Eckloniae) 10, the capital Rhizoma Pinelliae 6, Radix Glehniae 3, Poria 5, Semen Coicis 5, the Pseudobulbus Bletillae (Rhizoma Bletillae) 20, the Radix Stemonae 6, Bulbus Lilii 15, total amount is 100%.
2, the pill manufacture method, supervise that detection, treatment are noted, taboo and keeping require with example one.
3, clinical trial and effect
Warp is in example one described hospital, to 50 routine pulmonary tuberculosis human therapies, cure rate 88%, effective percentage 98%, invalid 2%.In this example, capital Rhizoma Pinelliae dosage is higher, but Radix Asparagi, Radix Ophiopogonis compatibility is arranged, so also do not produce any toxic side effects, all the other effects are with example one.
Example four
1, the raw medicinal material of Chinese patent medicine and percentage by weight are:
Radix Asparagi 4, sharp Bulbus Fritillariae Uninbracteatae 2, Radix Ophiopogonis 3, Colla Corii Asini 3, Bulbus Fritillariae Thunbergii 8, Thallus Laminariae (Thallus Eckloniae) 5, the capital Rhizoma Pinelliae 3, Radix Glehniae 5, Poria 8, Semen Coicis 15, the Pseudobulbus Bletillae (Rhizoma Bletillae) 30, the Radix Stemonae 9, Bulbus Lilii 5, total amount is 100%.
2, the Chinese patent medicine manufacture method, supervise that detection, treatment are noted, taboo, keeping require all with example together.
3, clinical trial and effect
Test hospital is with example one, and to 100 pulmonary tuberculosis human therapies, cure rate is 89%, and effective percentage is 100%.All the other effects are with example one.
Example five
1, the raw medicinal material of Chinese patent medicine and percentage by weight thereof are:
Radix Asparagi 6, sharp Bulbus Fritillariae Uninbracteatae 5, Radix Ophiopogonis 4, Colla Corii Asini 2, Bulbus Fritillariae Thunbergii 3, Thallus Laminariae (Thallus Eckloniae) 6, the capital Rhizoma Pinelliae 2, Radix Glehniae 2, Poria 7, Semen Coicis 5, the Pseudobulbus Bletillae (Rhizoma Bletillae) 46, the Radix Stemonae 5, Bulbus Lilii 7, total amount is 100%.
2, the Chinese patent medicine manufacture method, supervise and detect, use attention, taboo, keeping require all with example together.
3, clinical trial and effect
In the hospital of example one to 80 routine tuberculosis treatments, cure rate 90%, effective percentage 100%.All the other effects are with example one.
Pharmacology and effect analysis.This Chinese patent medicine is made by proportioning and method by above-mentioned Chinese crude drug, overcome the compatibility that conventional Chinese patent medicine should be mended with YIN nourishing merely, except that using the phthisical medicine Pseudobulbus Bletillae (Rhizoma Bletillae) of treatment, the Radix Stemonae, Bulbus Lilii, Radix Glehniae, also be furnished with the lung tissue of perfecting, take into account kidney,liver,spleen, stomach, intestinal, the heart, germ-resistant medicine, and be aided with nutrient substance such as egg, Mel, make lung strong, the lung disease disappears thereupon.Therefore, this Chinese patent medicine has strengthening vital QI to eliminate pathogenic factors, recovery, strong lung tissue and physiological function, YIN nourishing is supported lung, soft sharp eliminating stagnation blood stasis dispelling, granulation promoting bacterium for killing insect, cough-relieving, clearing away lung-heat and have prevention, health care, treatment one effect, reach treating both the principal and secondary aspects of a disease, the effect that different disease is ruled together, also weak to pulmonary tuberculosis tuberculous pleurisy, cough haematemesis, tracheitis, children's's pigeon chest, the deficiency of the lung, lung abscess etc. has certain curative effect.This Chinese patent medicine except that capital summer (making according to a conventional method) small toxicity by the Rhizoma Pinelliae, warm in nature, other are that nontoxic, property is flat or cold, sweet, therefore, any toxic and side effects is not found in clinical trial.So this Chinese patent medicine has unique curative effect to pulmonary tuberculosis, general effective percentage reaches more than 98%, and cure rate is more than 88%.Make with above-mentioned raw medicinal material, inexpensive, thereby economic and practical.
Claims (2)
1, the phthisical Chinese patent medicine pill of a kind of treatment, it is characterized in that: it is to be made by the following raw material medicines in percentage by weight material:
Radix Asparagi 1-6, sharp Bulbus Fritillariae Uninbracteatae 2-10, Radix Ophiopogonis 2-10, Colla Corii Asini 1-6,
Bulbus Fritillariae Thunbergii 1-8, Thallus Laminariae (Thallus Eckloniae) 5-10, capital Rhizoma Pinelliae 1-6, Radix Glehniae 1-5,
Poria 5-15, Semen Coicis 5-15, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-60, Radix Stemonae 5-15,
Bulbus Lilii 5-15, total amount is 100%.
2, the manufacture method of the phthisical Chinese patent medicine of the described treatment of claim 1, it is characterized in that: at first with the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Ophiopogonis, Radix Asparagi, the Radix Stemonae, Thallus Laminariae (Thallus Eckloniae) is with 80 ℃ to 120 ℃ moderate heat parch, the Pseudobulbus Bletillae (Rhizoma Bletillae) was fried 1 to 2 hour, Radix Asparagi, fried Radix Ophiopogonis 0.5 to 1 hour, the Radix Stemonae was fried 20 minutes to 1 hour, Thallus Laminariae (Thallus Eckloniae) was fried 20 minutes to 40 minutes, again with Semen Coicis, Bulbus Lilii, Poria, Bulbus Fritillariae Thunbergii, Radix Glehniae, the point Bulbus Fritillariae Uninbracteatae is under 50 ℃ to 70 ℃ low baking temperature or dry and dewater, then with the treated Chinese crude drug and the capital Rhizoma Pinelliae made by the Rhizoma Pinelliae, by its percentage by weight metering, be ground into powder, at last with the Mel refinery of dosage, Colla Corii Asini evaporates, and makes pill with the Chinese drugs powder mix homogeneously.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96117648A CN1068209C (en) | 1996-07-30 | 1996-07-30 | Feijiwan pill (for lung disease) and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96117648A CN1068209C (en) | 1996-07-30 | 1996-07-30 | Feijiwan pill (for lung disease) and preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1146359A CN1146359A (en) | 1997-04-02 |
CN1068209C true CN1068209C (en) | 2001-07-11 |
Family
ID=5124481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96117648A Expired - Fee Related CN1068209C (en) | 1996-07-30 | 1996-07-30 | Feijiwan pill (for lung disease) and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1068209C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101313986B (en) * | 2008-06-06 | 2011-10-26 | 叶志军 | Orally taken traditional Chinese medicine for treating cough caused by dryness-heat |
CN102600280B (en) * | 2012-03-26 | 2013-07-31 | 许凤霞 | Traditional Chinese medical composition for treatment of pediatric cough |
CN103285296A (en) * | 2013-06-28 | 2013-09-11 | 刘克志 | Traditional Chinese medicine for treating phthisis |
CN105250849A (en) * | 2015-11-20 | 2016-01-20 | 文永忠 | Chuangen Duanmi pills |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083385A (en) * | 1993-09-10 | 1994-03-09 | 顾春生 | A kind of herbal composite for the treatment of pulmonary tuberculosis cavity |
-
1996
- 1996-07-30 CN CN96117648A patent/CN1068209C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083385A (en) * | 1993-09-10 | 1994-03-09 | 顾春生 | A kind of herbal composite for the treatment of pulmonary tuberculosis cavity |
Non-Patent Citations (4)
Title |
---|
《中国农村医学》(11) 1989.11.30 方国明 自拟养阴固肺汤治疗肺结核咯血86例疗效分析 * |
《四川中医》8(8) 1990.8.31 刘学勉 益气疗肺汤治肺痨 * |
《陕西中医》13(11) 1992.11.30 乔桌妮 中西医结合治疗老年肺结核五十四例 * |
《陕西中医》13(11) 1992.11.30 乔桌妮 中西医结合治疗老年肺结核五十四例;《四川中医》8(8) 1990.8.31 刘学勉 益气疗肺汤治肺痨;《中国农村医学》(11) 1989.11.30 方国明 自拟养阴固肺汤治疗肺结核咯血86例疗效分析 * |
Also Published As
Publication number | Publication date |
---|---|
CN1146359A (en) | 1997-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100411649C (en) | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis | |
CN1201668C (en) | Healthy cold tea and producing method thereof | |
CN1947790A (en) | Medicine for treating paralysis and its prepn. method | |
AU749922B2 (en) | A medicament for treating recurrent ulcer of mouth and Behcet's syndrome | |
CN104189034B (en) | One analgesic bone leads to external use plaster and preparation method thereof | |
CN101590184B (en) | Traditional Chinese medicine combination for treating gout and preparation method thereof | |
CN103638190B (en) | The Chinese medicine for the treatment of acute cholecystitis | |
CN1068209C (en) | Feijiwan pill (for lung disease) and preparation method | |
CN101028325B (en) | Medicinal composition containing sailonggu, and its preparation and quality detection method | |
CN101537160A (en) | Health product for toxicant elimination and beauty maintenance | |
CN1618454A (en) | Medicinal composition for treating acne and beauty-care, and its prepn. method | |
CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
CN102526639B (en) | Chinese medicinal composition for treating hyperlipidemia and preparation method thereof | |
CN100335119C (en) | Chinese medicinal composition for treating enteritis | |
CN102641373A (en) | Traditional Chinese medicine combination used for treating psoriasis | |
CN102218131B (en) | External Chinese herbal medicine composition for promoting tissue regeneration and knitting bones | |
CN105770436A (en) | Ointment for burns and scalds | |
CN105596769A (en) | Traditional Chinese medicine for treating scalds, bedsores and hemorrhoid | |
CN1857660A (en) | Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer | |
CN1618439A (en) | Broad-specturm medicine for treating snake venom poisoning | |
CN1057680C (en) | Traditional Chinese medicine for curing dysentery | |
CN102671143B (en) | Parslane herb Chinese medicinal oral liquid for treating dysentery and preparation method for parslane herb Chinese medicinal oral liquid | |
CN108143769A (en) | A kind of deep medicine puree and preparation method of Chinese medicine external treatment rheumatic arthritis | |
CN1032571C (en) | Plaster for preventing and treating infant's diarrhoea and anorexia and preparing process thereof | |
CN102631496B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |